Emma Carr

Emma Carr is an experienced professional in market access and health economics, currently serving as the Director of Market Access at Novo Nordisk. Prior to this role, Emma held positions including Head of Market Access at Amryt Pharma DAC and Head of Patient Access & Community Engagement at Sobi - Swedish Orphan Biovitrum AB. Emma also worked as a Senior Payer Strategy Leader for Rare Diseases at Roche and as Director of Value, Access & Policy for Amgen in the European region. Emma Carr holds a PhD in Pharmacology from the University of Cambridge and an MSc in Health Economics from City, University of London.